Design Therapeutics, Inc. (DSGN)

Name: Design Therapeutics, Inc. (DSGN) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001807120 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Design Therapeutics, Inc. reported revenue of $0. Over the twelve months to 2026-06-30, revenue was $0.

Key ratios (year ended 2025-12-31)

-32.8%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-03

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$0	$0	$0	n/a	n/a	n/a	n/a
R&D Expense	$58.78M	$59.13M	$44.35M	$57.06M	$48.61M	$24.78M	$6.06M
Operating Income	-$79.36M	-$79.47M	-$62.38M	-$78.19M	-$67.59M	-$35.83M	-$8.33M
Net Income	-$70.80M	-$69.79M	-$49.59M	-$66.86M	-$63.31M	-$35.53M	-$8.28M
EPS (Diluted)	n/a	-$1.22	-$0.88	-$1.19	-$1.14	-$0.77	n/a
Total Assets	$215.13M	$226.20M	$252.09M	$289.64M	$341.14M	$390.56M	$36.52M
Total Liabilities	$13.27M	$13.70M	$10.00M	$11.96M	$13.83M	$8.43M	$2.48M
Shareholders' Equity	$201.86M	$212.50M	$242.10M	$277.69M	$327.31M	$382.13M	-$11.31M
Cash & Equivalents	$12.91M	$16.86M	$22.56M	$21.20M	$26.50M	$298.57M	$2.38M
Operating Cash Flow	-$55.08M	-$54.36M	-$43.10M	-$58.56M	-$51.32M	-$29.38M	-$8.67M
Capital Expenditures	$55.0K	$193.0K	$340.0K	$256.0K	$918.0K	$1.54M	$76.0K
Free Cash Flow	-$55.14M	-$54.55M	-$43.45M	-$58.82M	-$52.23M	-$30.91M	-$8.74M
Shares Outstanding	62.58M	60.40M	56.75M	56.47M	55.90M	55.44M	15.96M
Weighted Average Diluted Shares	n/a	57.33M	56.59M	55.98M	55.71M	45.94M	n/a
EPS (Basic)	n/a	-$1.22	-$0.88	-$1.19	-$1.14	-$0.77	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView